The 36th annual national leadership forum of CADCA will be held February 2-5, 2026 in National Harbor, Maryland. For more information, go to https://www.cadca.org/signature-events/
The 36th annual national leadership forum of CADCA will be held February 2-5, 2026 in National Harbor, Maryland. For more information, go to https://www.cadca.org/signature-events/
The federal government has extended temporarily — for the fourth time — the ability of patients to be inducted on methadone or buprenorphine without an in-person visit. Only opioid treatment programs (OTPs) can do the methadone inductions.
Researchers have found that for clinically complex patients, collaborative care for mental illness and opioid use disorder (OUD) may not be any more effective than usual care enhanced by care managers.
An analysis based on data for more than 40,000 users of agonist medication treatment for opioid use disorder (OUD) in British Columbia, Canada, has found less favorable population health outcomes associated with buprenorphine/naloxone compared with methadone. The research team reported that any reduced mortality risk for buprenorphine patients while in treatment was offset by poorer treatment retention with buprenorphine.
Last month, Neighborhood Health Plan of Rhode Island (Neighborhood) celebrated CODAC Behavioral Healthcare for earning an Honorable Mention in the Association for Community Affiliated Plans' (ACAP) Supporting the Safety Net Award. Neighborhood, an ACAP member, nominated CODAC for all its work removing barriers to care. The Supporting the Safety Net Award recognizes a community-based organization or individual whose work goes beyond the norm by developing and applying innovative practices to address the medical, behavioral, or social needs of high-risk populations in their service area.
The 36th annual national leadership forum of CADCA will be held February 2-5, 2026 in National Harbor, Maryland. For more information, go to https://www.cadca.org/signature-events/
As always, ADAW's Preview issue includes a review of stories in the previous year. Obviously, we couldn't include everything in the 48 eight-page issues — there are more than 250 articles in the newsletter's 2025 archives. But we focus on some significant areas and stories of interest.
According to the Substance Abuse and Mental Health Services Administration (SAMHSA), raising awareness of treatment, including medications to treat substance use disorders, is a key part of Treatment Month. SAMHSA is seeking to.
You probably do know that the Substance Abuse and Mental Health Services Administration (SAMHSA) is a shell of its former self. This agency was full of people who cared, half of whom have been let go, while those who remain are not talking publicly about how miserable they feel. All we want to say in this space is: don't give up, SAMHSA. And ADAW readers: Don't give up on them.
As a year of staggering policy upheaval came to a close, ADAW asked leaders in the substance use treatment, recovery and advocacy communities to project what 2026 will look like. The comments we received, presented here in a question-and-answer format, were edited for space, style and clarity.
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：